Huang Wen-Qiu, Burgers Peter C, Amin Mohamadreza, Luider Theo M, Ten Hagen Timo L M
Precision Medicine in Oncology (PrMiO) Department of Pathology, and Nanomedicine Innovation Center Erasmus (NICE) Erasmus MC Cancer Institute 3015 GD Rotterdam The Netherlands.
Clinical and Cancer Proteomics Department of Neurology Erasmus MC 3015 GD Rotterdam The Netherlands.
Small Sci. 2023 Jun 27;3(8):2300084. doi: 10.1002/smsc.202300084. eCollection 2023 Aug.
In nanomedicine, lipid-based nanoparticles (NPs) such as liposomes (LPs) have established an important position. Precise delineation of NP interaction with cells and detailed characterization of activity are becoming essential, which mainly rely on labeling with lipophilic fluorescent molecules and assuming stable association with NPs. However, because of label separation from NPs in (biological) media, or when processed by cells, fluorescence-based detection of an NP incorporating a single label may not necessarily indicate the actual presence of an NP but may be from the dissociated label, rendering results unreliable. Herein, flow cytometry and confocal microscopy are employed to demonstrate that to verify the localization of LPs in a cell with perfect accuracy, dual-labeling, and contemporaneous detection of both fluorescent signals in one pixel are required. This is combined with size exclusion chromatography (SEC) and mass spectrometry measurements to indicate factors involved in label dissociation, which helps to understand the possible conditions of dissociated label and NP. It is shown that determining label colocalization with, and label dissociation from, dual-labeled NPs are needed to provide accurate spatiotemporal insight into targeting destination (colocalized signals) and disintegration (separated signals) of NPs during intracellular processing and in studying payload delivery with precision in nanomedicine.
在纳米医学中,脂质基纳米颗粒(NPs)如脂质体(LPs)已占据重要地位。精确描绘NP与细胞的相互作用以及详细表征其活性变得至关重要,这主要依赖于用亲脂性荧光分子标记并假定其与NP稳定结合。然而,由于在(生物)介质中或细胞处理过程中标记与NP分离,基于荧光检测掺入单个标记的NP不一定表明NP的实际存在,而可能来自解离的标记,导致结果不可靠。在此,采用流式细胞术和共聚焦显微镜来证明,要以完美的精度验证LP在细胞中的定位,需要双标记并在一个像素中同时检测两个荧光信号。这与尺寸排阻色谱(SEC)和质谱测量相结合,以表明参与标记解离的因素,这有助于了解解离标记和NP的可能情况。结果表明,确定双标记NP的标记共定位以及标记解离,对于在细胞内处理过程中以及在纳米医学中精确研究载药递送时,准确洞察NP的靶向目的地(共定位信号)和分解(分离信号)的时空情况是必要的。